Guardant Health

$118.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.02 (+5.34%) Today

$0.00 (0.00%) As of 6:28 AM EST after-hours

Why Robinhood?

You can buy or sell GH and other stocks, options, and ETFs commission-free!

About GH

Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA. The listed name for GH is Guardant Health, Inc. Common Stock.

CEO

Helmy Eltoukhy

Employees

622

Headquarters

Redwood City, California

Founded

2012

Market Cap

11.86B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.36M

High Today

$118.88

Low Today

$113.12

Open Price

$113.77

Volume

388.04K

52 Week High

$122.31

52 Week Low

$55.90

Collections

Analyst Ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

GH Earnings

-$0.78

-$0.52

-$0.26

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 22, After Hours